Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
TLRs may contribute to the progression of rheumatoid arthritis through recognition of microbial or host-derived ligands found in arthritic joints. Here, we show that TLR2 and TLR4, but not TLR9, are involved in the pathogenesis of autoimmune arthritis and play distinct roles in the regulation of T cells and cytokines. We investigated the involvement of TLR2, TLR4, and TLR9 in the progression of arthritis using IL-1 receptor antagonist-knockout (IL1rn-/-) mice, which spontaneously develop an autoimmune T cell-mediated arthritis. Spontaneous onset of arthritis was dependent on TLR activation by microbial flora, as germ-free mice did not develop arthritis. Clinical and histopathological evaluation of IL1rn-/-Tlr2-/- mice revealed more severe arthritis, characterized by reduced suppressive function of Tregs and substantially increased IFN-gamma production by T cells. IL1rn-/-Tlr4-/- mice were, in contrast, protected against severe arthritis and had markedly lower numbers of Th17 cells and a reduced capacity to produce IL-17. A lack of Tlr9 did not affect the progression of arthritis. While any therapeutic intervention targeting TLR2 still seems complicated, the strict position of TLR4 upstream of a number of pathogenic cytokines including IL-17 provides an interesting potential therapeutic target for rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Spontaneous development of T cell-mediated autoimmune arthritis in IL1rn–/– mice requires the activation of TLR2 and TLR4 by microbial ligands.174”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [174]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 1×
“TLRs are primarily involved in innate immune response to microbial pathogens through recognition of conserved pathogen-associated molecular patterns (1); however, they also contribute to sterile inflammation by sensing the “danger signals,” i.”
BackgroundSelf-citationControl of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · cited 1×
“The major function of Tregs is to inhibit other T cells from mounting an immune attack against self components and to prevent autoimmunity (54, 55).”
BackgroundFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“The major function of Tregs is to inhibit other T cells from mounting an immune attack against self components and to prevent autoimmunity (54, 55).”
BackgroundBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · cited 1×
“Recent findings identified IL-17 as a crucial disease-promoting factor in autoimmune disorders and showed an inhibitory effect of IFN-γ on Th17 development from naive T cells (42, 43); however, IL-17 production by effector and memory Th17 cells in the presence of IL-23 was not inhibited by IFN-γ.”
BackgroundA distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“Recent findings identified IL-17 as a crucial disease-promoting factor in autoimmune disorders and showed an inhibitory effect of IFN-γ on Th17 development from naive T cells (42, 43); however, IL-17 production by effector and memory Th17 cells in the presence of IL-23 was not inhibited by IFN-γ.”
BackgroundInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 2×
“Conditioned medium of TLR4-stimulated DCs has been shown to replace IL-6, IL-1β, and TNF-α in Th17 cell differentiation (51).”
BackgroundTransforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279 · cited 1×
“Foxp3 is considered the most specific marker for Tregs, and its expression directly correlates with the suppressor activity of these cells, irrespective of CD25 expression (46, 47).”
BackgroundPhenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861 · cited 1×
“The presence of a similar “Th1/Th17” subset has also been demonstrated in the gut of patients with Crohn disease (45).”
BackgroundPark, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., & Abraham, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,562 · cited 9×
“Here, we report that TLR2 and TLR4, but not TLR9, are involved in the expression of autoimmune arthritis in IL1rn–/– model.”
BackgroundInfluentialFoxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
The Extra Domain A of Fibronectin Activates Toll-like Receptor 4
Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., & Strauss, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100099200 · Cited by 1,216
Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., & Enk, A. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271209 · Cited by 1,163
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Sousa, C. R. E., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R. N., & Sher, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1819 · Cited by 911
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
Wan, Y. Y., & Flavell, R. A. (2007) · Nature · doi:10.1038/nature05479 · Cited by 854 · cited 1×
“Attenuated Foxp3 expression abrogates the immune-suppressive, but not hypoproliferative, activities of Tregs and results in an aggressive autoimmune syndrome (48).”
BackgroundSchaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850 · cited 9×
“Here, we report that TLR2 and TLR4, but not TLR9, are involved in the expression of autoimmune arthritis in IL1rn–/– model.”
BackgroundInfluentialToll-like receptor 2 controls expansion and function of regulatory T cells
Sutmuller, R. P. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25439 · Cited by 756 · cited 4×
“TLR2 has been reported to modulate some T cell subsets, such as Th2 and Tregs (10, 15, 16, 38).”
BackgroundInfluentialHorai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749 · cited 2×
“Discussion IL1rn–/– mice develop an autoimmune destructive arthritis that exhibits several characteristics of RA (33).”
BackgroundAgrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 725
Lubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
Self-citationToll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells
Re, F., & Strominger, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105927200 · Cited by 691 · cited 1×
“Activation of TLRs forms an important bridge between innate and adaptive immunity by regulating the expression of costimulatory molecules on APCs to drive T cell activation and by creating a cytokine milieu to conduct the differentiation of T cells into the desired subset (5).”
BackgroundJohnson, G. B., Brunn, G. J., Kodaira, Y., & Platt, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5233 · Cited by 648
Netea, M. G., Sutmuller, R., Hermann, C., Van der Graaf, C. A. A., Van der Meer, J. W. M., van Krieken, J. H., Hartung, T., Adema, G., & Kullberg, B. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3712 · Cited by 609 · cited 1×
“In addition, Tlr2–/– mice have significantly lower number of Tregs due to lower IL-10 concentrations (12).”
BackgroundBelghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter
Wan, Y. Y., & Flavell, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501701102 · Cited by 576 · cited 1×
“Foxp3 is considered the most specific marker for Tregs, and its expression directly correlates with the suppressor activity of these cells, irrespective of CD25 expression (46, 47).”
Background(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Self-citationNakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S., & Iwakura, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035999100 · Cited by 490 · cited 14×
“Higher IL-17 production by CD3-stimulated IL1rn–/– lymphocytes was in line with data reported previously (35).”
BackgroundResultInfluentialVabulas, R. M., Braedel, S., Hilf, N., Singh-Jasuja, H., Herter, S., Ahmad-Nejad, P., Kirschning, C. J., da Costa, C., Rammensee, H.-G., Wagner, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200425200 · Cited by 488 · cited 9×
“Here, we report that TLR2 and TLR4, but not TLR9, are involved in the expression of autoimmune arthritis in IL1rn–/– model.”
BackgroundInfluentialDillon, S., Agrawal, A., Van Dyke, T., Landreth, G., McCauley, L., Koh, A., Maliszewski, C., Akira, S., & Pulendran, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4733 · Cited by 460
Self-citationRedecke, V., Häcker, H., Datta, S. K., Fermin, A., Pitha, P. M., Broide, D. H., & Raz, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2739 · Cited by 448 · cited 1×
“On the other hand, TLR2 has been reported to induce a Th2-biased immune response capable of aggravating experimental asthma and to inhibit IFN-γ production by LPS-stimulated PBMCs (10, 11, 41).”
BackgroundZhai, Y., Shen, X.-D., O’Connell, R., Gao, F., Lassman, C., Busuttil, R. W., Cheng, G., & Kupiec-Weglinski, J. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7115 · Cited by 445
Toll-like receptor 2 signaling modulates the functions of CD4 + CD25 + regulatory T cells
Liu, H., Komai-Koma, M., Xu, D., & Liew, F. Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601554103 · Cited by 440 · cited 4×
“TLR2 has been reported to modulate some T cell subsets, such as Th2 and Tregs (10, 15, 16, 38).”
BackgroundInfluentialVeldhoen, M., Hocking, R. J., Flavell, R. A., & Stockinger, B. (2006) · Nature Immunology · doi:10.1038/ni1391 · Cited by 403
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Self-citationToll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival
Gelman, A. E., Zhang, J., Choi, Y., & Turka, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6065 · Cited by 386 · cited 1×
“org Volume 118 Number 1 January 2008 213 pressive properties of Tregs (18, 19, 39).”
BackgroundFrosch, M., Strey, A., Vogl, T., Wulffraat, N. M., Kuis, W., Sunderkötter, C., Harms, E., Sorg, C., & Roth, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<628::aid-anr20>3.0.co;2-x · Cited by 381
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Prinz, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26078 · Cited by 380 · cited 1×
“Although TLR9 activation has recently been implicated in other autoimmune diseases such as multiple sclerosis, possibly through its activation by endogenous “danger signals” (40), Tlr9 deficiency did not affect the incidence and the severity of IL1rn–/– autoimmune arthritis.”
BackgroundRoelofs, M. F., Joosten, L. A. B., Abdollahi‐Roodsaz, S., Van Lieshout, A. W. T., Sprong, T., van den Hoogen, F. H., Van Den Berg, W. B., & Radstake, T. R. D. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21278 · Cited by 334
Self-citationChabaud, M., Lubberts, E., Joosten, L., van den Berg, W., & Miossec, P. (2001) · Arthritis Research & Therapy · doi:10.1186/ar294 · Cited by 333 · cited 1×
“Furthermore, IL-17 is expressed in synovial sublining of RA patients (59) and inhibits collagen synthesis and bone formation in synovium and bone explants of RA patients (60).”
BackgroundSelf-citationRadstake, T. R. D. J., Roelofs, M. F., Jenniskens, Y. M., Oppers‐Walgreen, B., van Riel, P. L. C. M., Barrera, P., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20678 · Cited by 331
Self-citationArterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.303 · Cited by 317 · cited 1×
“IL1rn–/– mice on a BALB/c background were generated as described previously (67).”
MethodSelf-citationCho, M.-L., Kang, J.-W., Moon, Y.-M., Nam, H.-J., Jhun, J.-Y., Heo, S.-B., Jin, H.-T., Min, S.-Y., Ju, J.-H., Park, K.-S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5652 · Cited by 313 · cited 7×
“IL-23 can be induced by TLR4 and has been shown to play a central role in the pathogenesis of spontaneous arthritis in IL1rn–/– mice through induction of IL-17 (36).”
BackgroundInfluentialThe role of different subsets of T regulatory cells in controlling autoimmunity
Roncarolo, M.-G., & Levings, M. K. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00162-x · Cited by 310
Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Di Padova, F. E., Boots, A. M. H., Gram, H., Joosten, L. A. B., & van den Berg, W. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62961-6 · Cited by 310
Self-citationVan Der Heijden, I. M., Wilbrink, B., Tchetverikov, I., Schrijver, I. A., Schouls, L. M., Hazenberg, M. P., Breedveld, F. C., & Tak, P. P. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<593::aid-anr16>3.0.co;2-1 · Cited by 306
Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
Abdollahi‐Roodsaz, S., Joosten, L. A. B., Roelofs, M. F., Radstake, T. R. D. J., Matera, G., Popa, C., van der Meer, J. W. M., Netea, M. G., & van den Berg, W. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22848 · Cited by 302
Self-citationIntra-articularly localized bacterial DNA containing CpG motifs induces arthritis
Deng, G.-M., Nilsson, I.-M., Verdrengh, M., Collins, L. V., & Tarkowski, A. (1999) · Nature Medicine · doi:10.1038/9554 · Cited by 297
Expression and Regulation of Toll-Like Receptor 2 in Rheumatoid Arthritis Synovium
Seibl, R., Birchler, T., Loeliger, S., Hossle, J. P., Gay, R. E., Saurenmann, T., Michel, B. A., Seger, R. A., Gay, S., & Lauener, R. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63918-1 · Cited by 287
Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi-Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278
Self-citationIwahashi, M., Yamamura, M., Aita, T., Okamoto, A., Ueno, A., Ogawa, N., Akashi, S., Miyake, K., Godowski, P. J., & Makino, H. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20219 · Cited by 267
Re, F., & Strominger, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7548 · Cited by 222 · cited 1×
“On the other hand, TLR2 has been reported to induce a Th2-biased immune response capable of aggravating experimental asthma and to inhibit IFN-γ production by LPS-stimulated PBMCs (10, 11, 41).”
BackgroundSacre, S. M., Andreakos, E., Kiriakidis, S., Amjadi, P., Lundberg, A., Giddins, G., Feldmann, M., Brennan, F., & Foxwell, B. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060657 · Cited by 184 · cited 10×
“Here, we report that TLR2 and TLR4, but not TLR9, are involved in the expression of autoimmune arthritis in IL1rn–/– model.”
BackgroundInfluentialA simple sensitive bioassay for interleukin-1 which is unresponsive to 103 U/ml of interleukin-2
Gearing, A. J. H., Bird, C. R., Bristow, A., Poole, S., & Thorpe, R. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90025-1 · Cited by 168
Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis
Saal, J. G., Steidle, M., Einsele, H., Müller, C. A., Fritz, P., & Zacher, J. (1992) · Rheumatology International · doi:10.1007/bf00274934 · Cited by 144
Joosten, L. A. B., Radstake, T. R. D., Lubberts, E., van den Bersselaar, L. A. M., van Riel, P. L. C. M., van Lent, P. L. E. M., Barrera, P., & van den Berg, W. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10814 · Cited by 121 · cited 1×
“Furthermore, IL-17 is expressed in synovial sublining of RA patients (59) and inhibits collagen synthesis and bone formation in synovium and bone explants of RA patients (60).”
BackgroundSelf-citationEijnden, S. V., Goriely, S., Wit, D. D., Goldman, M., & Willems, F. (2005) · European Journal of Immunology · doi:10.1002/eji.200535467 · Cited by 121
Horai, R., Nakajima, A., Habiro, K., Kotani, M., Nakae, S., Matsuki, T., Nambu, A., Saijo, S., Kotaki, H., Sudo, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420742 · Cited by 121 · cited 3×
“The T cell cytokines TNF-α and IL-17 are known to play crucial roles in IL1rn–/– arthritis (34, 35), and IL-23 has recently been demonstrated to be the link between IL-1 and IL-17 (36).”
BackgroundPrince, J. M., Levy, R. M., Yang, R., Mollen, K. P., Fink, M. P., Vodovotz, Y., & Billiar, T. R. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.11.021 · Cited by 112
Saal, J. G., Krimmel, M., Steidle, M., Gerneth, F., Wagner, S., Fritz, P., Koch, S., Zacher, J., Sell, S., Einsele, H., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199907)42:7<1485::aid-anr24>3.0.co;2-7 · Cited by 107
Suryani, S., & Sutton, I. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.023 · Cited by 92 · cited 1×
“Very recently, the presence of a new T cell subtype producing both IFN-γ and IL-17, with more pathogenic characteristics compared with cells only producing IL-17, has been described in experimental autoimmune encephalomyelitis (44).”
Backgroundvan de Loo, F. A. J., Arntz, O. J., Otterness, I. G., & van den Berg, W. B. (1992) · PubMed · Cited by 92
The distribution of fibronectin in the pannus in rheumatoid arthritis.
Scott, D. L., Delamere, J. P., & WALTON, K. W. (1981) · PubMed · Cited by 85
LaRosa, D. F., Gelman, A. E., Rahman, A. H., Zhang, J., Turka, L. A., & Walsh, P. T. (2007) · Immunology Letters · doi:10.1016/j.imlet.2006.12.007 · Cited by 79 · cited 2×
“Activation of TLR4 is important for the survival of pathogenic Th17 cells through induction of IL-23 production by DCs (17); and, finally, TLR9 ligand CpG DNA inhibits CD4+CD25+ Treg–mediated suppression of the effector T cells (18, 19).”
BackgroundChiffoleau, E., Heslan, J., Heslan, M., Louvet, C., Condamine, T., & Cuturi, M. C. (2006) · International Immunology · doi:10.1093/intimm/dxl136 · Cited by 52 · cited 2×
“Activation of TLR4 is important for the survival of pathogenic Th17 cells through induction of IL-23 production by DCs (17); and, finally, TLR9 ligand CpG DNA inhibits CD4+CD25+ Treg–mediated suppression of the effector T cells (18, 19).”
BackgroundThe diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses
Kiura, K., Kataoka, H., Yasuda, M., Inoue, N., & Shibata, K. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00119.x · Cited by 50 · cited 1×
“TLR2 has been reported to modulate some T cell subsets, such as Th2 and Tregs (10, 15, 16, 38).”
BackgroundYolton, D. P., Stanley, C., & Savage, D. C. (1971) · Infection and Immunity · doi:10.1128/iai.3.6.768-773.1971 · Cited by 44 · cited 1×
“Monocontamination of germ-free animals with only 1 indigenous microflora, Lactobacillus bifidus (37), resulted in rapid onset of arthritis that reached incidence rate and severity scores comparable to those in non–germ-free mice (Figure 1, A and B).”
ResultWalle, T., VARTIO, T., Helve, T., Virtanen, I., & Kurki, P. (1990) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1990.tb02802.x · Cited by 32
Jelaska (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200010)43:10 · Cited by 2
Research works printed but not linked: 2
- Scott, 1981, Br. J. Exp. Pathol., 62, 362
- van de Loo, 1992, J. Rheumatol., 19, 348
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
“Spontaneous development of T cell-mediated autoimmune arthritis in IL1rn mice requires the activation of TLR2 and TLR4 by microbial ligands.(174) Dysbiotic microbiota from IL1rn mice elicits a IL17 response by intestinal lymphocytes.”
BackgroundOsteoarthritis: A disease of the joint as an organ
Loeser, R. F., Goldring, S. R., Scanzello, C. R., & Goldring, M. B. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34453 · Cited by 3,076
“TLR-4 deficiency reduced disease severity in a model of inflammatory arthritis (93), but efficacy of specific TLR deficiency or blockade has not yet been reported in models of OA.”
BackgroundRole of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E. G., Abramson, S. B., et al. (2013) · eLife · doi:10.7554/elife.01202 · Cited by 2,047
“However, the introduction of specific gut bacterial species is sufficient to induce joint inflammation (Rath et al., 1996; Abdollahi-Roodsaz et al., 2008; Wu et al., 2010), and antibiotic treatment both prevents and abrogates a rheumatoid arthritis-like phenotype in several mouse models.”
Background
Metadata
- Authors
- Abdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R. D. J., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M. J. H., Ribeiro-Dias, F., & van den Berg, W. B.
- Affiliations
- Radboud University Medical Center (NL)
- Research Institute for Microbial Diseases, The University of Osaka (JP)
- University of Sheffield (GB)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 1
- Pages
- 205-216
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2104479
- OpenAlex
- W2107300453
- Cited by
- 527
- References
- 71
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 16 · 2023: 29 · 2022: 24 · 2021: 31 · 2020: 26 · 2019: 33 · 2018: 31 · 2017: 28 · 2016: 43 · 2015: 33 · 2014: 28 · 2013: 35 · 2012: 39
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Educação
- Dutch Arthritis Association
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TLR2, TLR4, TLR9, rheumatoid arthritis, autoimmune arthritis, Treg suppressive function, Th17 cells, IL-17, interferon-gamma, interleukin-1 receptor antagonist, germ-free mice, microbiota, T cell differentiation, cytokine production, therapeutic target
- MeSH terms
- Animals, Arthritis, Rheumatoid, Disease Models, Animal, Germ-Free Life, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Knockout, Interleukin-17, T-Lymphocytes, Regulatory, Toll-Like Receptor 2, Toll-Like Receptor 4, Toll-Like Receptor 9, Mice, Interleukin 1 Receptor Antagonist Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.